Lucid Diagnostics (LUCD) Return on Sales Growth (3y) (2024 - 2026)
Lucid Diagnostics (LUCD) Return on Sales Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | 0.00 |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 0.00 |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 0.00 |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 0.00 |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | 0.00 |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | 0.00 |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 0.00 |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | 0.00 |
| 10 | Lucid Diagnostics | 129.48 Mn | 101.60 Mn | -325,000.00 | 26.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.00 |
| Dec 31, 2025 | 122.00 |
| Sep 30, 2025 | 180.00 |
| Jun 30, 2025 | 62.00 |
| Mar 31, 2025 | 32.00 |
| Dec 31, 2024 | 28.00 |
| Sep 30, 2024 | 24.00 |